Role of p38 MAP Kinase Signal Transduction in Solid Tumors

Hari K Koul1, Mantu Pal2, Sweaty Koul3

  • 1Department of Biochemistry & Molecular Biology, LSU Health Sciences Center, Shreveport, LA, USA ; Feist-Weiller Cancer Center, Shreveport, LA, USA ; Veterans Administration Medical Center, Shreveport, LA, USA.

Genes & Cancer
|December 19, 2013
PubMed

Insights

Mitogen-activated protein kinases (MAPKs), specifically p38 MAPK, regulate cell behaviors crucial for cancer progression. Targeting p38 MAPK pathways offers a promising strategy for treating solid tumors.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Oncology

Background:

  • Mitogen-activated protein kinases (MAPKs) are key signaling molecules mediating cellular responses to external stimuli.
  • The p38 MAPK subgroup regulates critical cellular processes including proliferation, differentiation, death, migration, and invasion.
  • Aberrant p38 MAPK levels correlate with advanced cancer stages and poor prognosis in various solid tumors.

Purpose of the Study:

  • To review recent advancements in understanding p38 MAPK pathway functions in solid tumor biology.
  • To explore the dual role of p38 MAPK in cell survival and death.
  • To generate hypotheses regarding p38 MAPK as a therapeutic target for solid tumors.

Main Methods:

  • Literature review of laboratory findings on p38 MAPK signaling.
  • Analysis of p38 MAPK's role in cell migration and invasion.
  • Exploration of cell type-specific and stimulus-dependent functions of p38 MAPK.

Main Results:

  • p38 MAPK exhibits context-dependent roles in cell survival and death.
  • p38 MAPK significantly influences cancer cell migration and invasion, key aspects of metastasis.
  • The specific function of p38 MAPK is modulated by cell type, stimuli, and activated isoforms.

Conclusions:

  • p38 MAPK signaling is a critical regulator in solid tumor biology.
  • The pathway's involvement in cell migration and invasion presents a targetable vulnerability for anti-cancer therapies.
  • Further research extrapolating laboratory findings is essential for clinical application of p38 MAPK targeting.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K